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OBJECTIVE: The aim of this study was to determine the in vitro effect of glutamine and insulin on apoptosis,
mitochondrial membrane potential, cell permeability, and inflammatory cytokines in hyperglycemic umbilical
vein endothelial cells.
MATERIALS AND METHODS: Human umbilical vein endothelial cells were grown and subjected to glutamine
and insulin to examine the effects of these agents on the hyperglycemic state. Mitochondrial function and the
production of inflammatory cytokines were assessed using fluorescence analysis and multiple cytotoxicity
assays. Apoptosis was analyzed by the terminal deoxynucleotidyl transferase dUTP nick end-labeling assay.
RESULTS: Glutamine maintains the integrity of the mitochondria by reducing the cell permeability and
cytochrome c levels and increasing the mitochondrial membrane potential. The cytochrome c level was
significantly (po0.005) reduced when the cells were treated with glutamine. An apoptosis assay revealed
significantly reduced apoptosis (po0.005) in the glutamine-treated cells. Moreover, glutamine alone or in
combination with insulin modulated inflammatory cytokine levels. Interleukin-10, interleukin-6, and vascular
endothelial growth factor were up-regulated while tumor necrosis factor-a was down-regulated after
treatment with glutamine.
CONCLUSION: Glutamine, either alone or in combination with insulin, can positively modulate the mitochondrial
stress and cell permeability in umbilical vein endothelial cells. Glutamine regulates the expression of
inflammatory cytokines and maintains the balance of the mitochondria in a cytoprotective manner.
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’ INTRODUCTION
Hyperglycemia is the abnormality underlying diabetes
and several other complications. Chronic hyperglycemia
condition initiates a wide range of complications, including
cardiovascular disease, which is the most frequent cause of
death in the diabetic population (1,2). Hyperglycemia also
induces the production of reactive oxygen species (ROS) and,
ultimately, DNA damage and apoptosis (3). Apoptosis has
been observed in the vascular cells, myocardium, and nerves
of diabetic experimental animals and human subjects,
although whether it contributes to or is a marker for
complications in these tissues is unclear. Vascular diseases
are the major cause of morbidity and mortality in diabetic
patients. Several studies suggest that the endothelium is the
initial site where these vascular complications develop (4).
During critical illness, hyperglycemia alone or hyperglyce-
mia coupled with a relative insulin deficiency may directly or
indirectly yield a predisposition to a spectrum of complica-
tions, such as multi-organ failure and death (5-7). Morpho-
logical correlates of these functional abnormalities were not
initially identified; however, several later studies showed an
increase in apoptosis in several organs affected by diabetes
and sepsis, including the eye (8,9), heart, and vascular
endothelium (10,11).DOI: 10.6061/clinics/2015(08)07
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Vascular endothelial cells are among the first cells in the
body to interact with bacterial endotoxins during sepsis.
Sepsis is a very complex and heterogeneous clinical
condition that is associated with hyperglycemia and insulin
resistance (12). Vascular endothelial cells possess mechan-
isms that recognize structural patterns of bacterial constitu-
ents and initiate the expression of proinflammatory and
anti-inflammatory pathways, which are tightly controlled
to maintain homeostatic balance (13). However, in severe
sepsis, external stimuli, such as a severe infection, can
activate the immune cells and unleash a systemic inflamma-
tory response that is expressed through various pathways
(14). There is also increasing evidence to suggest that cell
death by apoptosis plays an important role in the pathogen-
esis of severe sepsis/septic shock (15).
Several studies have shown that endothelial cells can
undergo apoptosis in response to sepsis-related factors such
as Lipopolysaccharide (LPS) and Tumor necrosis factor alpha
(TNF-a) (16-18). In addition, studies using in vitro models of
infection have demonstrated that certain organisms are
capable of inducing endothelial apoptosis (19). Along with
the interaction of inflammation with apoptosis in sepsis,
mitochondrial dysfunction seems to have a major impact in
sepsis patients because it has been closely linked to pro-
grammed cell death. Alterations in mitochondrial function
have been described in the muscle and liver mitochondria
from septic rats and primates. Furthermore, mitochondrial
dysfunction has been suggested as a potential mechanism to
explain tissue hypoxia despite normal oxygen availability
during sepsis (20,21). Pro-inflammatory cytokines, such as
interleukin 6 (IL-6), TNF-a, and other molecules, are released
during acute inflammation and result in endothelial activation
and a significant increase in the expression of endothelial
leukocyte adhesion molecule 1, vascular cell adhesion mole-
cule 1 (VCAM-1), intercellular adhesion molecule 1 (ICAM-1),
and vascular endothelial growth factor (VEGF). These proteins
promote leukocyte rolling, adherence, and migration, which
initiate inflammation in the endothelium and other cells
(22,23). We included IL-10 as an anti-inflammatory marker.
Therefore, the aim of this study was to determine the
mechanism of endothelial cell apoptosis and the expression
of inflammatory cytokines under hyperglycemic conditions
and to examine the effects of glutamine and insulin.
’ MATERIALS AND METHODS
Cell culture
Endothelial cells were obtained from VEC Technologies
(New York, USA). The cells were thawed at 37 ˚C and
cultured in T25 flasks coated with 50 mg/ml of fibronectin.
The cells were immersed in 5 ml of complete medium
(MCDB-B-131), supplemented with 10% FBS, 1% penicillin-
streptomycin, and epidermal growth factor (EGF, 10 ng/ml).
The cells were incubated at 37 ˚C with 5% CO2. Trypsin/
EDTA (1 ml for each flask) was used to detach the cells upon
confluency. All the experiments were performed at passages
2-5.
Cell treatment
The cells were seeded at 1x104 cells in each well and
incubated for 24 hours. Various concentrations of glucose,
ranging from a normal value (5 mM) to a hyperglycemic
level (20 mM), were added to the individual wells. The
hyperglycemic cells (glucose concentration 20 mM) were
divided into three groups. In the first group, 40 mM of gluta-
mine was added. In the second group, 1.0 x 10-6 units/ml of
insulin was added. In the third group, glutamine (40 mM)
and insulin (1.0 x 10-6 units/ml) were added. The cells were
then incubated for the required length of time (24 hours). For
the cytokine and TUNEL analyses, 0.7x106 cells were grown
in T25 flasks using the same treatment groups. The cells were
harvested and frozen until required for analysis.
Western blotting
The endothelial cells were first lysed in cold lysis buffer
containing 20 mmol/l of TRIS HCl, 140 mmol/l of NaCl, 1
mmol/l of EDTA and complete miniprotease inhibitor cock-
tail, 1% Triton X-100, 0.1% SDS, 1% sodium deoxycholate, 1
mmol/l NaF, and 1 mmol orthovanadate. The proteins (30 mg)
were then loaded on 10% SDS polyacrylamide gels and
transferred to activated nitrocellulose membranes. The mem-
branes were blocked with Tris-buffered saline (TBS) contain-
ing 5% nonfat milk and incubated overnight with the primary
antibodies to IL-10 and TNF-a, obtained from Santa Cruz, at
4 ˚C. Beta-actin was used as a loading control. After extensive
washes in TBS, the membranes were incubated for one hour at
room temperature with the appropriate horseradish perox-
idase-conjugated secondary antibodies, and the proteins were
visualized using a chemiluminescence substrate according to
the manufacturer’s instructions (Amersham Life Sciences).
Multiple cytotoxicity assays
The Cellomics Multiparameter Cytotoxicity 3–kit was used
as previously reported in detail by Cheah et al. (24). The
Multiparameter Cytotoxicity 3–kit enables parallel measure-
ments of six independent parameters that monitor cell
health, namely, changes in cell permeability, cell loss and
nuclear size; changes in mitochondrial membrane potential;
cytochrome c release; and morphological changes. Briefly, the
cells were plated at 1x104 cells per well for 24 hours. Glucose
(5 or 20 mM), glutamine (40 mM), and insulin (1.0 x 10-6
units/ml) were added in different combinations as described
in the cell treatment section, and the incubation was
continued for 24 hours. The MMP dye and the cell
permeability dye were added to the live cells, and the cells
were incubated for 1 hour. The cells were fixed, permeabi-
lized, and blocked with 1 blocking buffer before they were
incubated with the primary cytochrome c antibody and
conjugated secondary antibody for 1 hour. The cells were
rinsed three times with wash buffer II, and the plates were
analyzed using the Array Scan HCS high content system
(Cellomics, PA, USA).
Measurement of transmembrane mitochondrial
potential
The mitochondrial transmembrane potential results from
the asymmetric distribution of protons and other ions on the
two sides of the inner mitochondrial membrane, which gives
rise to the chemical, pH, and electric gradients that are
essential for mitochondrial function. The inner side of the
inner mitochondrial membrane is negatively charged. Con-
sequently, cationic lipophilic fluorochromes are distributed
within the mitochondrial matrix as a function of the Nernst
equation describing the transmembrane mitochondrial
potential (c). Using a cytofluorometer, these dyes were
employed to measure variations in the transmembrane
potential (c) on a per-mitochondrion or per-cell basis.
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Terminal deoxynucleotidyl transferase dUTP nick
end-labeling (TUNEL) assay
DNA damage was investigated using a 96–well colori-
metric apoptosis detection kit (R&D System) according to the
manufacturer’s instructions. Umbilical vein endothelial cells
were cultured and transferred to a 96-well plate (1x105 cells/
well). The cells were then fixed with 3.7% buffered
formaldehyde for 5 minutes, followed by washing with
PBS. The washing was followed by permeabilization of the
cells with 100% methanol for 20 minutes and another wash
with PBS. Following the manufacturer’s protocol, the cells
were then subjected to the labeling procedure, and the
reaction was stopped with 0.2 N HCl after 30 minutes. The
cells were treated with NucleaseTM to generate DNA breaks
and to confirm the permeabilization and labeling reactions.
An unlabeled control was included to indicate the level of
background labeling associated with non-specific binding of
the Strep-HRP. The absorbance at 450 nm was measured
using a microplate reader.
Cytokine measurements
The cytokines TNF-a, IL-6, and IL-10 were measured in
triplicate using the Protein Bio-Plex Cytokine Assay (Bio-Rad
Laboratories). T25 flasks containing 0.7x106 cells were
cultured, and the lysate was filter-sterilized (0.22-mm pore
size). The protein concentrations were determined, and the
Bio-Plex Cytokine Assay (Bio-Rad Laboratories) was con-
ducted according to the manufacturer’s protocol. The
calculated concentrations for each cytokine were averaged,
and the standard deviations were determined. Statistical
significance was determined using the t-test, where po0.05
designated increased/decreased cytokine production in the
presence of glutamine or glutamine in combination with
insulin.
Statistical analysis
Each experiment was performed at least two times.
Statistical analysis was performed using one-way analysis
of variance (ANOVA).
’ RESULTS
Glutamine reduces the cytochrome C levels and
apoptosis in hyperglycemic human umbilical vein
endothelial cells
Umbilical vein endothelial cells were stained with Hoechst
in the presence of glucose (20 mM) alone, 20 mM glucose +
40 mM glutamine, 20 mM glucose + 10-6 M insulin, or 20
mM glucose + 40 mM glutamine + 10-6 M insulin, and the
staining intensity was determined. As shown in Figures 1
and 2, glucose alone (20 mM) reduced the number of cells,
possibly by apoptosis, as well as reduced the level of
Figure 1 - Representative images of endothelial cells treated with medium alone (control), glucose alone (20mM), glucose (20mM) +
insulin (10-6 M), glucose (20mm)+ glutamine (40mM) and glucose (20mM)+ glutamine (40mM)+ insulin (10-6 M). Cells were stained
with Hoechst for nuclear, cell permeability dye, mitochondrial membrane potential dye and cytochrome c. The image from each row
was obtained from the same field of the same treatment sample (magnification 20 xs).
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cytochrome c. There was a significant change (po0.005) in
the fluorescence intensity in the cells that were treated with
glucose along with glutamine. This result indicates that these
cells were more viable. In addition, the cytochrome c levels in
the endothelial cells treated with glucose (20 mM) +
glutamine (40 mM) were significantly (po0.005) lower than
the levels in the cells treated with glucose (20 mM) alone. The
cytochrome c levels in the cells treated with glucose (20 mM)
+ insulin (10-6 M) and glucose (20 mM)+ insulin (10-6 M)+
glutamine (40 mM) also changed significantly (po0.05)
compared with the levels in the cells treated with glucose
(20 mM) alone (Figures 1 and 2B). Similarly, the TUNEL
assay revealed a significantly reduced level of apoptosis
when the hyperglycemic cells were treated with insulin
(po0.05), glutamine (po0.005), or glutamine + insulin
(po0.005) (Figure 2A).
Glutamine restores the loss of mitochondrial
membrane potential (MMP) in Human Umbilical
Endothelial Cells (HUVEC)
According to previous studies, a reduction in the
mitochondrial membrane potential occurs when cells
undergo oxidative stress and hyperglycemia in the
presence of other co-factors. The cells showed a signifi-
cant change in the MMP when treated with glutamine
and a considerable, but not significant, change in the
MMP when they were treated with glucose + glutamine
+ insulin compared with 20 mM glucose only. Glucose
(20 mM) + insulin (10-6 M) and glucose (20 mM)+ insulin
(10-6 M)+ glutamine (40 mM) also yielded an increase in the
MMP (DCm) compared with the control. These results show
that the MMP was reduced after the cells had been treated
Figure 2 - Shows (A) TUNEL assay which revealed a significantly reduced apoptosis when hyperglycemic cells were treated with insulin
(po0.05) glutamine (po0.005) and glutamine + insulin (po0.005). (B) Cytochrome c intensity for the endothelial cells treated with
glucose (20 mM)+ glutamine (40 mM) significantly changes when compare to glucose (20 mM) alone. Cytochrome c intensity for the
cells treated with glucose (20 mM) + insulin (10-6 M) and glucose (20 mM) + insulin (10-6 M) + glutamine (40 mM) changes
insignificantly as compare to glucose (20 mM) alone. (C) and (D) show mitochondrial membrane potential and cell permeability
respectively.
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with 20 mM glucose alone; however, glucose (20 mM) in
combination with glutamine (40 mM) was shown to be more
protective against the fall in the MMP and oxidative stress-
induced cell death (Figure 2C).
Effect of glutamine on cell permeability
When the MMP decline reaches a certain point, the
opening of the permeability transition pore (PTP) starts to
cause extensive cell damage and, consequently, cell death.
The hyperglycemia-induced permeability was reversed
when we treated the HUVECs with glucose + glutamine
or glucose + glutamine + insulin compared with glucose
(20 mM) alone. However, there was a slight increase in the
cell permeability when the cells were treated with glucose (20
mM) + insulin (10-6 M) (Figure 2D).
Glutamine and inflammatory cytokines
When glucose (20 mM) and insulin (10-6 M) were added to
the culture, there was no difference in the expression of IL-6.
However, glucose + glutamine significantly increased the
expression of IL-6. The combined treatment with glucose
(20 mM), glutamine (40 mM), and insulin (10-6 M) also
significantly increased the expression of IL-6 (po0.005).
Similarly, treatment with insulin alone did not alter the
expression of IL-10, but insulin in combination with
glutamine increased the expression of IL-10 in the endothe-
lial cells. A small increase in the expression of VEGF was
noted while a reduced expression of TNF-a was observed
when the cells were treated with the same concentration of
glutamine alone or in combination with insulin (Figure 3A,
3B, 3C, and 3D). Detailed values of all cytokines are given in
Table 1. IL-10 is the most important anti-inflammatory
Figure 3 - (A) shows that insulin did not alter the expression of IL–10 when treated alone but insulin in combination with glutamine
increased IL–10 in endothelial cells (po0.05). (B) Shows a significantly reduced TNF–a when cells were treated with the same
concentration of glutamine in combination with insulin. (C) IL–6 expression which is significantly increased when treated with
glutamine in combination with insulin (po0.005). (D) A mild increase in the expression of VEGF was noted when treated with
glutamine or glutamine in combination with insulin.
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cytokine found within the human response. It is a potent
inhibitor of Th1 cytokines and a potent activator of
monocyte/macrophage proinflammatory cytokine synthesis.
In addition, IL-10 attenuates the surface expression of TNF
receptors and promotes the shedding of the TNF receptors
into the systemic circulation. Furthermore, there is an
interesting relationship between IL-10 and the soluble TNF-
a receptor. Specifically, when IL-10 increases, it causes an
increase in the levels of the soluble TNF-a receptor, which
results in decreased TNF-a levels. To confirm this effect, we
carried out Western blotting for IL-10 and TNF-a (Figure 4).
The levels of both IL-10 and TNF-a changed in the same
manner, as shown in Figure 3.
’ DISCUSSION
Our results show that glutamine, either alone or in
combination with insulin, disrupts mitochondrial stress and
improves cell viability. Anti-inflammatory cytokines were highly
expressed in the glutamine-treated cells. With respect to
cytochrome C, there was a significant change in the fluorescence
intensity in the cytosol in the cells treated with glutamine alone,
indicating an increase in the viability of the cells (Figure 2B) on
the basis that increased cytochrome c levels in the cells trigger
programmed cell death through apoptosis (25,26). Similarly,
there was an increase in the mitochondrial potential (Figure 2C).
Our results demonstrate that the cytochrome c levels in cells
are increased under hyperglycemic conditions. This protein is
known for its function in the mitochondria as a key participant
in the life-supporting function of ATP. Our data also support the
hypothesis that hyperglycemia, through the production of
oxidative stress, could be an apoptotic stimulus that triggers
the release of cytochrome c into the cytosol, thereby activating
the mitochondrial pathway that leads to the permeabilization of
the outer mitochondrial membrane and increasing the level of
cytochrome c (27,28). In the cytosol, cytochrome c engages
apoptotic protease activating factor-1 (APAF1) and forms the
apoptosome. The cell then dies via the apoptotic pathway or
necrosis due to the collapse of electron transport, generation of
oxygen free radicals, and production of ATP (29,30). As shown
in Figure 2B, in our study, the level of cytochrome c in cells
Figure 4 - (A) shows the effect of insulin and glutamine on the expression of IL–10 and TNF–a in endothelial cell. (B) shows significantly
reduced IL–10 and (C) shows TNF–a in graphical form.
Table 1 - Cytokine analysis comparing 20 mM glucose, 20 mM
glucose + Ins, 20 mM glucose + Gln, and 20 mM glucose + Ins
+ Gln.
Variable Group n Mean p-value
Hu IL-6 20 mM 3 55.5
20 mM+Ins 3 56.2 NS
20 mM+Gln 3 73.7 0.035
20 mM+Ins+Gln 3 91.0 0.004
Hu IL-10 20 mM 3 26.3
20 mM+Ins 3 27.5 NS
20 mM+Gln 3 32.2 NS
20 mM+Ins+Gln 3 34.8 0.011
Hu TNF-a 20 mM 3 13.3
20 mM+Ins 3 12.8 NS
20 mM+Gln 3 10.7 NS
20 mM+Ins+Gln 3 9.7 0.006
Hu VEGF (45) 20 mM 3 22.0
20 mM+Ins 3 20.7 NS
20 mM+Gln 3 22.5 NS
20 mM+Ins+Gln 3 24.7 NS
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cultured in 20 mM glucose (hyperglycemic conditions) was
significantly reduced by the addition of glutamine (40 mM), and
the viability of the cells was thus increased compared with that
of cells incubated with insulin alone or insulin plus glutamine.
Cells induced to undergo apoptosis show an early
reduction in the incorporation of c-sensitive dyes, which
indicates a decrease in the transmembrane potential. This
transmembrane potential disruption can be detected in many
different cell types, irrespective of the apoptosis-inducing
stimulus. The transmembrane potential disruption occurs
before the cells exhibit nuclear DNA fragmentation, indicat-
ing that the membrane potential change constitutes an early
common event of the apoptotic cascade. Purified cells with a
low transmembrane potential rapidly proceed to DNA
fragmentation. In our study, there was a decrease in the
mitochondrial potential under the hyperglycemic condition,
suggesting that hyperglycemia could act as an apoptosis-
inducing stimulus. The decrease in the mitochondrial
potential was reduced in the presence of glutamine or
glutamine plus insulin (Figure 2C), although this reduction
did not reach significance in the case of glutamine and
insulin combined. An intact transmembrane potential (c) is
indispensable for normal mitochondrial function because
cells undergoing apoptosis cease mitochondrial biogenesis at
both the translational and transcriptional level (31). More-
over, during apoptosis, mitochondrial inner membrane
proteins, including cytochrome c, leak out into the cytosol.
Mitochondria play a central role in the apoptotic process,
in which the dissipation of MMP, increased mitochondrial
oxidant production, and release of apoptogenic proteins
(e.g., apoptosis-inducing factor and cytochrome c) caused
by opening of the permeability transition pore are observed.
In our study, the cell permeability was increased under
hyperglycemic conditions, but the permeability was reduced
in the cells treated with glutamine (Figure 2D).
Recent evidence (32) has implicated a general dysregula-
tion of the endothelium, with apoptosis and necrosis as the
final pathway of endothelial dysfunction and with mito-
chondrial dysfunction caused by the central disruption of
cellular oxidative function. We therefore hypothesized that
mitochondrial dysfunction may also be present in endothe-
lial cells during hyperglycemia and may reflect the degree of
systemic injury in patients with severe sepsis and hypergly-
cemia. Stress-induced hyperglycemia and insulin resistance
are exceedingly common in critically ill patients, particularly
in those with sepsis. Multiple pathogenic mechanisms are
responsible for this metabolic syndrome, with the increased
release of proinflammatory mediators and counter-regula-
tory hormones playing a pivotal role (33). Recent data
suggest that hyperglycemia may potentiate the proinflam-
matory response, while insulin has the opposite effect.
To investigate the possibility that hyperglycemia plays a
key role in the development of the inflammatory response in
sepsis, we assessed the patterns of IL-6, TNF-a, VEGF, and
IL-10 that are associated with severe sepsis. In an exploratory
analysis, one study (34) demonstrated that by using multiple
cytokine assays, distinct cytokine profiles were found to be
associated with the severity of sepsis, the development of
organ failure, and death. The inflammatory cytokines IL-1b,
IL-6, IL-8, IL-10, and TNF-a have been shown to be
associated with the various stages of severe sepsis. To
determine whether the same group of cytokines was
expressed under hyperglycemic conditions, we assessed the
expression of IL-6, TNF-a, VEGF, and IL-10. In our study, we
determined the effect of insulin and glutamine on the
expression of IL-6, a cytokine with anti–inflammatory and
proinflammatory functions. When insulin was added to the
cultures, there was no difference in the expression of
IL-6 (Figure 3), but glutamine had an additive effect with
insulin, and the combination of glutamine and insulin
significantly increased the expression of IL-6. Like many
other cytokines, IL-6 has both pro–inflammatory and anti-
inflammatory properties. Recent evidence generated using
IL-6 knockout mice has demonstrated that IL-6, like other
members of the gp130 receptor ligand family, acts predomi-
nantly as an anti–inflammatory cytokine. IL-6 down-reg-
ulates the synthesis of IL-1 and TNF-a and attenuates the
synthesis of pro–inflammatory cytokines. Simultaneously,
IL-6 inhibits the production of pro–inflammatory cytokines,
including GM–CSF, IFNg, and MIP2. Interestingly, IL-6 may
down-regulate TNF-a and IL-b production and may be
important in limiting the inflammatory response. Our results
demonstrate the same limiting response of IL-6 on TNF-a;
however, VEGF was unexpectedly up-regulated by the
glutamine treatment. The net results of these immunologic
effects place IL-6 among the anti-inflammatory group (35).
The expression of IL-10 (Figure 3) was increased by
treatment with glutamine and insulin, with the addition of
insulin having an additive effect. IL-10 is the most important
anti-inflammatory cytokine in humans. It is a potent
inhibitor of the Th1 cytokines and a potent deactivator of
monocyte/macrophage pro-inflammatory cytokine synth-
esis. In addition, IL-10 attenuates the surface expression of
TNF receptors and promotes the shedding of the TNF
receptors into the systemic circulation (35-37).
The above cytokines have both anti-inflammatory and pro–
inflammatory functions (38). Therefore, even during an
inflammatory disease such as sepsis, it is important to maintain
both the inflammatory and anti-inflammatory cytokines, and
this balance seems to be achievable by the effect of glutamine.
According to previous reports, glutamine supplementation has
been shown to maintain the T–lymphocyte population in the
spleen and to significantly enhance the mRNA expression
levels of Th1 and Th2 cytokines and TNF-a in the spleens of
rats with septic peritonitis (39,40).
Pharmacological supplementation with glutamine helps to
maintain the intestinal barrier, modulate cytokine production,
and prevent organ injury during sepsis. However, the exact
protective mechanism remains to be explored. It has already
been demonstrated that glutamine significantly attenuates the
plasma levels of cytokines produced by macrophages and
endothelial cell necrosis after cecal ligation and puncture in rats
(41,42). Recently, it was reported that glutamine treatment
directly augmented macrophage TNF-a production in vitro but
decreased TNF-a release in vivo, even though the expression of
HSP72 was increased in both cases (43). Another report
suggests that dietary glutamine administration results in higher
inflammatory cytokine production and greater neutrophil
recruitment during the early stage of acute lung injury (44).
In conclusion, our data suggest that glutamine alone or in
combination with insulin can modulate the production of
inflammatory and anti-inflammatory cytokines and maintain
the cytokine balance under hyperglycemic conditions,
producing a cytoprotective effect. At the same time, our
data indicate that glutamine maintains the integrity of the
mitochondria, the dysfunction of which in hyperglycemic
endothelial cells may reflect the degree of systemic injury in
severe sepsis.
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